These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 709377)

  • 1. Cerebral metabolism of glucose in adrenalectomized rats: effect of treatment with L-DOPA and a monoamine oxidase inhibitor.
    Tyce GM; Owen CA
    Brain Res; 1978 Dec; 158(2):466-9. PubMed ID: 709377
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM
    J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the administration of L-5-hydroxytryptophan and a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    J Neurochem; 1978 Sep; 31(3):613-20. PubMed ID: 308095
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridoxal 5'-phosphate levels in brain after treatments which impair cerebral glucose metabolism.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Dec; 4(6):821-6. PubMed ID: 44547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.
    Finberg JP; Gross A; Bar-Am O; Friedman R; Loboda Y; Youdim MB
    Br J Pharmacol; 2006 Nov; 149(6):647-56. PubMed ID: 17016505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):134-40. PubMed ID: 666453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dihydroxyphenylalanine administered with a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Tyce GM
    Biochem Pharmacol; 1971 Sep; 20(9):2371-84. PubMed ID: 5163149
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism by L-dopa of the elevation of hypothalamic epinephrine by monoamine oxidase inhibition in rats.
    Fuller RW; Hemrick-Luecke SK
    Biochem Pharmacol; 1981 Nov; 30(21):3023-4. PubMed ID: 7317098
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR; Palfreyman MG; Robin M; Zreika M
    Br J Pharmacol; 1986 Jan; 87(1):257-64. PubMed ID: 3082400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl 1-alanine and its analogs.
    DeFeudis FV
    Rev Clin Basic Pharm; 1988; 7(1-4):207-8. PubMed ID: 3247497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of L-3,4-dihydroxyphenylalanine (L-dopa) on the incorporation of radioactive amino acids into rat brain protein.
    King MD; Beesley PW
    Biochem Soc Trans; 1978; 6(5):1000-2. PubMed ID: 744300
    [No Abstract]   [Full Text] [Related]  

  • 13. Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol.
    Bhattacharya SK; Glover V; Sandler M; Clow A; Topham A; Bernadt M; Murray R
    Biol Psychiatry; 1982 Jul; 17(7):829-36. PubMed ID: 7115834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry.
    Kitahama K; Geffard M; Araneda S; Arai R; Ogawa K; Nagatsu I; Pequignot JM
    Brain Res; 2007 Sep; 1167():56-70. PubMed ID: 17692830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase.
    Teychenne PF; Calne DB; Lewis PJ; Findley LJ
    Clin Pharmacol Ther; 1975 Sep; 18(3):273-7. PubMed ID: 1164817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory action of L-dihydroxyphenylalanine (L-dopa) in the presence of a monoamine oxidase inhibitor on protein synthesis in vivo and the partial amelioration of this by methionine supplementation.
    Bone AH; Taufek HR
    Biochem J; 1980 Nov; 192(2):703-7. PubMed ID: 7236233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.
    Heeringa MJ; d'Agostini F; DeBoer P; DaPrada M; Damsma G
    J Neural Transm (Vienna); 1997; 104(6-7):593-603. PubMed ID: 9444560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of harmine on plasma concentrations of L-dopa and on cerebral dopamine metabolism in rabbits and rats.
    Meneguz A; Betto P; Ricciarello G
    Pharmacology; 1994 Jun; 48(6):360-6. PubMed ID: 8047555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.